NCT04337580 2026-02-20
FASN
Wake Forest University Health Sciences
Phase 2 Recruiting
Clinical Trials
7 trialsNCT04717154 2026-01-06
INSPIRE
Radboud University Medical Center
Phase 2 Completed
NCT05393791 2024-11-26
ANZadapt
Leiden University Medical Center
Phase 2 Recruiting
NCT04918810 2024-11-22
GUIDE
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Terminated
NCT03248570 2024-11-20
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
University of California, San Francisco
Phase 2 Completed
NCT03173859 2020-11-18
AERA
University of Athens
Phase 2 Withdrawn
NCT02254785 2017-12-06
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
British Columbia Cancer Agency
Phase 2 Unknown